New Program

Precision medicine has the potential to transform how we treat or even cure cancer and other genetic diseases. However, inefficiencies continue to slow the advancement of this breakthrough treatment approach. Challenges of this magnitude cannot be solved through scientific endeavors alone; they require novel business solutions.

This program strives to address this problem by convening leaders from the scientific, medical, technological, and business communities to explore business models in precision medicine—also known as personalized medicine—and work together to accelerate progress in this burgeoning area.

What You Can Expect

Created by the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, this program brings together senior leaders from diverse organizations and expertise areas to explore new models in personalized medicine. Led by HBS faculty at the forefront of this emerging area, the program presents new methods for engaging patients in their care, expanding access to critical data, improving clinical trials, and targeting investments that can fuel scientific treatment breakthroughs.

Read More

Created by the Harvard Business School (HBS) Kraft Precision Medicine Accelerator, this program brings together senior leaders from diverse organizations and expertise areas to explore new models in personalized medicine. Led by HBS faculty at the forefront of this emerging area, the program presents new methods for engaging patients in their care, expanding access to critical data, improving clinical trials, and targeting investments that can fuel scientific treatment breakthroughs.

Read More

Your Course of Study

Through a series of timely case studies, this program will present different scenarios that demonstrate many of the challenges and opportunities prevalent in precision medicine. Complemented by lectures from top experts, these case studies will challenge you to examine the critical role of data in targeted immunotherapies, evaluate various investment models, review problem-solving strategies in clinical trials, and investigate best practices in personalized medicine.

Read More

Through a series of timely case studies, this program will present different scenarios that demonstrate many of the challenges and opportunities prevalent in precision medicine. Complemented by lectures from top experts, these case studies will challenge you to examine the critical role of data in targeted immunotherapies, evaluate various investment models, review problem-solving strategies in clinical trials, and investigate best practices in personalized medicine.

Read More

Who Is Right for the Program

This program is designed for senior leaders who recognize precision medicine as a vital opportunity in their industry and want to develop an actionable plan for driving it forward. These leaders may work in business, science, medicine, or technology, and they may or may not focus on cancer specifically. Organizations are encouraged to send teams of two to four individuals who are working on a project in a particular disease area.

Read More

This program is designed for senior leaders who recognize precision medicine as a vital opportunity in their industry and want to develop an actionable plan for driving it forward. These leaders may work in business, science, medicine, or technology, and they may or may not focus on cancer specifically. Organizations are encouraged to send teams of two to four individuals who are working on a project in a particular disease area.

Read More

About The Kraft Precision Medicine Accelerator

The HBS Kraft Precision Medicine Accelerator was established in 2016 with a $20 million endowment from the Robert and Myra Kraft Family Foundation, Inc. Its mission is to speed medical breakthroughs in precision medicine, the process by which genomic information and other unique characteristics of a person's disease are used to predict which treatments will be most effective. The HBS Kraft Precision Medicine Accelerator convenes best-in-class leaders from the business, medical, scientific, and technological communities to identify and solve challenges slowing the advancement of precision medicine, disseminate best practices and models to overcome these challenges, and ultimately enable the faster commercialization of high-impact innovations.

Read More

The HBS Kraft Precision Medicine Accelerator was established in 2016 with a $20 million endowment from the Robert and Myra Kraft Family Foundation, Inc. Its mission is to speed medical breakthroughs in precision medicine, the process by which genomic information and other unique characteristics of a person's disease are used to predict which treatments will be most effective. The HBS Kraft Precision Medicine Accelerator convenes best-in-class leaders from the business, medical, scientific, and technological communities to identify and solve challenges slowing the advancement of precision medicine, disseminate best practices and models to overcome these challenges, and ultimately enable the faster commercialization of high-impact innovations.

Read More

Every Harvard Business School Executive Education program is developed and taught by HBS faculty who are widely recognized as skilled educators, groundbreaking researchers, and award-winning authors. Through publishing, consulting, and teaching, HBS faculty leverage their business expertise and field-based research to develop enduring concepts that shape the practice of management. The result is an Executive Education teaching team whose groundbreaking insights challenge participants' thinking and enable them to become superior business leaders.

Faculty Cochair
Henry and Allison McCance Family Senior Fellow of Business Administration. Senior Fellow and faculty cochair of the Kraft Precision Medicine Accelerator and cochair of "Accelerating Innovation in Precision Medicine." Founder of the Multiple Myeloma Research Foundation.  Read Full Bio
Faculty Cochair
Senior Fellow, MBA Class of 1961 Professor of Management Practice, Retired. Faculty cochair of the Kraft Precision Medicine Accelerator and cochair of "Accelerating Innovation in Precision Medicine." Founding Faculty chair of the HBS Health Care Initiative. Read Full Bio

View Entire Teaching Team

Every Harvard Business School Executive Education program is developed and taught by HBS faculty who are widely recognized as skilled educators, groundbreaking researchers, and award-winning authors. Through publishing, consulting, and teaching, HBS faculty leverage their business expertise and field-based research to develop enduring concepts that shape the practice of management. The result is an Executive Education teaching team whose groundbreaking insights challenge participants' thinking and enable them to become superior business leaders.

Kathy E. Giusti

Faculty Cochair
Henry and Allison McCance Family Senior Fellow of Business Administration. Senior Fellow and faculty cochair of the Kraft Precision Medicine Accelerator and cochair of "Accelerating Innovation in Precision Medicine." Founder of the Multiple Myeloma Research Foundation.

Richard G. Hamermesh

Faculty Cochair
Senior Fellow, MBA Class of 1961 Professor of Management Practice, Retired. Faculty cochair of the Kraft Precision Medicine Accelerator and cochair of "Accelerating Innovation in Precision Medicine." Founding Faculty chair of the HBS Health Care Initiative.

View Entire Teaching Team

Admissions

The Admissions Committee meets monthly, and admits qualified candidates on a rolling, space available basis. Early application is strongly encouraged. Please submit your application at least four weeks before the program start date. Since qualified candidates are admitted on a rolling, space-available basis, early application is encouraged. Admission is selective and based on professional achievement and organizational responsibility. Although there are no formal educational requirements, proficiency in written and spoken English is essential. Because Executive Education programs enhance the leadership capacity of the participants as well as their organizations, HBS expects the full commitment of both. While participants are attending a program, sponsoring organizations agree to relieve them of their work responsibilities so that they can fully focus on the learning experience.

Read More

The Admissions Committee meets monthly, and admits qualified candidates on a rolling, space available basis. Early application is strongly encouraged. Please submit your application at least four weeks before the program start date. Since qualified candidates are admitted on a rolling, space-available basis, early application is encouraged. Admission is selective and based on professional achievement and organizational responsibility. Although there are no formal educational requirements, proficiency in written and spoken English is essential. Because Executive Education programs enhance the leadership capacity of the participants as well as their organizations, HBS expects the full commitment of both. While participants are attending a program, sponsoring organizations agree to relieve them of their work responsibilities so that they can fully focus on the learning experience.

Read More

Programs, dates, fees, and faculty are subject to change.

In accordance with Harvard University policy, Harvard Business School does not discriminate against any person on the basis of race, color, sex or sexual orientation, gender identity, religion, age, national or ethnic origin, political beliefs, veteran status, or disability in admission to, access to, treatment in, or employment in its programs and activities.

Related Resources

View all related resources